1. Home
  2. PLUR vs MYND Comparison

PLUR vs MYND Comparison

Compare PLUR & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • MYND
  • Stock Information
  • Founded
  • PLUR 2001
  • MYND 1998
  • Country
  • PLUR Israel
  • MYND United States
  • Employees
  • PLUR N/A
  • MYND N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • MYND Other Consumer Services
  • Sector
  • PLUR Health Care
  • MYND Real Estate
  • Exchange
  • PLUR Nasdaq
  • MYND Nasdaq
  • Market Cap
  • PLUR 36.9M
  • MYND 37.0M
  • IPO Year
  • PLUR N/A
  • MYND 2017
  • Fundamental
  • Price
  • PLUR $3.91
  • MYND $0.66
  • Analyst Decision
  • PLUR Strong Buy
  • MYND
  • Analyst Count
  • PLUR 1
  • MYND 0
  • Target Price
  • PLUR $12.00
  • MYND N/A
  • AVG Volume (30 Days)
  • PLUR 10.5K
  • MYND 25.3K
  • Earning Date
  • PLUR 11-11-2025
  • MYND 08-27-2025
  • Dividend Yield
  • PLUR N/A
  • MYND N/A
  • EPS Growth
  • PLUR N/A
  • MYND N/A
  • EPS
  • PLUR N/A
  • MYND N/A
  • Revenue
  • PLUR $1,336,000.00
  • MYND $209,800,000.00
  • Revenue This Year
  • PLUR $97.38
  • MYND N/A
  • Revenue Next Year
  • PLUR $293.97
  • MYND N/A
  • P/E Ratio
  • PLUR N/A
  • MYND N/A
  • Revenue Growth
  • PLUR 309.82
  • MYND N/A
  • 52 Week Low
  • PLUR $3.33
  • MYND $0.53
  • 52 Week High
  • PLUR $7.13
  • MYND $3.89
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 41.69
  • MYND 38.69
  • Support Level
  • PLUR $3.60
  • MYND $0.60
  • Resistance Level
  • PLUR $4.09
  • MYND $0.70
  • Average True Range (ATR)
  • PLUR 0.18
  • MYND 0.06
  • MACD
  • PLUR -0.02
  • MYND -0.01
  • Stochastic Oscillator
  • PLUR 30.69
  • MYND 23.88

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

Share on Social Networks: